The Pharmacy and Poisons Board (PPB) has lifted a suspension it ordered on December 11, 2024, of a drug used for mild pain relief. In a statement on Monday, March 17, 2025, the board revealed that following thorough assessments, the Mefnac Oral Suspension had met the required standards. “The Pharmacy and Poisons Board (“the Board”) […]
